Dosage and utilization of dexamethasone in the management of COVID-19: A critical review

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Virol. Sep 25, 2024; 13(3): 95709
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.95709

Full Size Figure Download Figure

Figure 2 Pooled odds ratio for 28-day mortality rates.

Citation: Sethi I, Shaikh A, Sethi M, Chohan HK, Younus S, Khan SA, Surani S. Dosage and utilization of dexamethasone in the management of COVID-19: A critical review. World J Virol 2024; 13(3): 95709
URL: https://www.wjgnet.com/2220-3249/full/v13/i3/95709.htm
DOI: https://dx.doi.org/10.5501/wjv.v13.i3.95709

Sethi I, Shaikh A, Sethi M, Chohan HK, Younus S, Khan SA, Surani S. Dosage and utilization of dexamethasone in the management of COVID-19: A critical review. World J Virol 2024; 13(3): 95709 [PMID: 39323444 DOI: 10.5501/wjv.v13.i3.95709]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.